Early immunological changes associated with laryngeal transplantation in a major histocompatibility complex-matched pig model

被引:15
作者
Barker, E.
Murison, P.
Macchiarini, P.
Jones, A.
Otto, C.
Rothkoetter, H. -J.
Haverson, K.
Bailey, M.
Birchall, M.
Stokes, C.
机构
[1] Univ Bristol, Laryngeal Res Grp, Fac Med & Dent, Bristol, Avon, England
[2] Univ Bristol, Dept Vet Clin Sci, Bristol, Avon, England
[3] Univ Hannover, Dept Funct Anat, Hannover, Germany
[4] Dept Thorac Surg, Hannover, Germany
基金
英国惠康基金;
关键词
larynx; pig; transplant;
D O I
10.1111/j.1365-2249.2006.03232.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Laryngeal transplantation is an increasingly viable proposition for patients with irreversible diseases of the larynx. One human transplant has been performed successfully, but many questions remain before routine transplantation can begin. In order to measure the immunological changes in mismatched transplants, it is first necessary to know the immediate combined effects of ischaemia-reperfusion injury (IRI) plus the added insult of major surgery in a fully matched setting. We measured the changes in immunologically active mucosal cells following 3 h of cold ischaemia and 8 h of in situ reperfusion in a major histocompatibility complex (MHC)-matched minipig model (n = 4). Biopsies were prepared for quantitative, multiple-colour immunofluorescence histology. The number of immunologically active cells was significantly altered above (supraglottis) and below (subglottis) the vocal cords following transplantation and reperfusion (P < 0.05, P < 0.001, respectively). However, the direction of the change differed between the two subsites: cell numbers decreased post-transplant in the supraglottis and increased in the subglottis. Despite the statistical evidence for IRI, these changes were less than the large normal inter- and intrapig variation in cell counts. Therefore, the significance of IRI in exacerbating loss of function or rejection of a laryngeal allograft is open to question. Longer-term studies are required.
引用
收藏
页码:503 / 508
页数:6
相关论文
共 33 条
[1]   The larynx as an immunological organ: immunological architecture in the pig as a large animal model [J].
Barker, E ;
Haverson, K ;
Stokes, CR ;
Birchall, M ;
Bailey, M .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 143 (01) :6-14
[2]  
BINNS RM, 1995, IMMUNOLOGY, V86, P25
[3]   Laryngeal transplantation in 2005: A review [J].
Birchall, MA ;
Lorenz, RR ;
Berke, GS ;
Genden, EM ;
Haughey, BH ;
Siemionow, M ;
Strome, M .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (01) :20-26
[4]   Model for experimental revascularized laryngeal allotransplantation [J].
Birchall, MA ;
Bailey, M ;
Barker, EV ;
Rothkötter, HJ ;
Otto, K ;
Macchiarini, P .
BRITISH JOURNAL OF SURGERY, 2002, 89 (11) :1470-1475
[5]   Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: Inhibition of late apoptosis and inflammation [J].
De Vries, B ;
Matthijsen, RA ;
Wolfs, TGAM ;
Van Bijnen, AAJHM ;
Heeringa, P ;
Buurman, WA .
TRANSPLANTATION, 2003, 75 (03) :375-382
[6]   Protective roles of polyethylene glycol and trimetazidine against cold ischemia and reperfusion injuries of pig kidney graft [J].
Faure, JP ;
Petit, I ;
Zhang, KQ ;
Dutheil, D ;
Doucet, C ;
Favreau, F ;
Eugène, M ;
Goujon, JM ;
Tillement, JP ;
Mauco, G ;
Vandewalle, A ;
Hauet, T .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (04) :495-504
[7]   An allelic non-histocompatibility antigen with wide tissue distribution as a marker for chimerism in pigs [J].
Fuchimoto, Y ;
Huang, C ;
Shimizu, A ;
Seebach, J ;
Arn, S ;
Sachs, DH .
TISSUE ANTIGENS, 1999, 54 (01) :43-52
[8]   A preclinical model for laryngeal transplantation: Anatomy and mucosal immunology of the porcine larynx [J].
Gorti, GK ;
Birchall, MA ;
Haverson, K ;
Macchiarini, P ;
Bailey, M .
TRANSPLANTATION, 1999, 68 (11) :1638-1642
[9]   Reduction of postischemic immune inflammatory response:: An effective strategy for attenuating chronic allograft nephropathy [J].
Herrero-Fresneda, I ;
Torras, J ;
Vidal, A ;
Lloberas, N ;
Cruzado, JM ;
Grinyó, JM .
TRANSPLANTATION, 2005, 79 (02) :165-173
[10]  
Hiller AS, 1998, SCAND J IMMUNOL, V47, P159